Lifestance HealthLFST
LFST
About: LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Employees: 7,535
0
Funds holding %
of 7,245 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
156% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 18
103% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 36
90% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $8.12M
16% more funds holding
Funds holding: 153 [Q4 2024] → 178 (+25) [Q1 2025]
1.28% more ownership
Funds ownership: 87.98% [Q4 2024] → 89.25% (+1.28%) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]
8% less capital invested
Capital invested by funds: $2.48B [Q4 2024] → $2.29B (-$195M) [Q1 2025]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$8
41%
upside
Avg. target
$8.50
50%
upside
High target
$9
59%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
Keybanc Steve Dechert | 59%upside $9 | Overweight Initiated | 8 Apr 2025 |
Canaccord Genuity Richard Close | 41%upside $8 | Buy Initiated | 3 Apr 2025 |
Financial journalist opinion
Based on 9 articles about LFST published over the past 30 days
Neutral
PRNewsWire
1 week ago
LifeStance Names Vaughn Paunovich as Chief Technology Officer
SCOTTSDALE, Ariz. , May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025.
Neutral
Seeking Alpha
1 week ago
LifeStance Health Group, Inc. (LFST) Q1 2025 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q1 2025 Results Conference Call May 7, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ryan McGroarty - CFO David Bourdon - CEO Conference Call Participants Craig Hettenbach - Morgan Stanley Jamie Perse - Goldman Sachs Ryan Daniels - William Blair Brian Tanquilut - Jefferies Richard Close - Canaccord Genuity Dylan Christopher - UBS Steven Dechert - KeyBanc Capital Markets Operator Good day, everyone, and thank you for standing by. My name is Arji, and I will be your conference operator today.
Positive
Zacks Investment Research
1 week ago
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Positive
Zacks Investment Research
1 week ago
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Neutral
Zacks Investment Research
2 weeks ago
LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1
LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.
Neutral
GlobeNewsWire
2 weeks ago
LifeStance Reports First Quarter 2025 Results
SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025.
Positive
Zacks Investment Research
2 weeks ago
Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade
The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Negative
Zacks Investment Research
3 weeks ago
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Positive
Seeking Alpha
4 weeks ago
LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion
I remain bullish on LifeStance Health Group stock due to robust demand, clinician retention, and margin expansion potential, despite recent share price declines. LFST's flexible hybrid care model and digital check-in tool enhance clinician retention and patient accessibility, driving sustainable growth and competitive advantage. LFST's adjusted EBITDA margin reached 10.1% in 4Q24, with management targeting 15-20% over time, supported by operational efficiencies and higher-margin services.
Neutral
GlobeNewsWire
1 month ago
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025
SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025.
Charts implemented using Lightweight Charts™